|
Market Closed -
Other stock markets
|
Pre-market 06:05:01 | |||
| 3.680 EUR | +18.90% |
|
3.628 | -1.41% |
| 05:12am | DBV Technologies Raises EUR167 Million from Exercise of Warrants | MT |
| 01-16 | European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Rise 2% for Week | MT |
| Capitalization | 1.09B 1.26B 1.01B 941M 1.75B 114B 1.89B 11.63B 4.59B 54.53B 4.73B 4.63B 199B | P/E ratio 2025 * |
-4.15x | P/E ratio 2026 * | -5.14x |
|---|---|---|---|---|---|
| Enterprise value | 1.02B 1.18B 945M 880M 1.64B 107B 1.76B 10.87B 4.29B 50.98B 4.42B 4.33B 186B | EV / Sales 2025 * |
190x | EV / Sales 2026 * | 250x |
| Free-Float |
98.83% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: DBV Technologies
More recommendations
More press releases
More news
| 1 day | +18.90% | ||
| 1 week | +21.65% | ||
| Current month | +8.88% | ||
| 3 months | +26.03% | ||
| 6 months | +115.46% | ||
| Current year | +8.88% |
| 1 week | 2.92 |  | 3.7 |
| 1 month | 2.86 | | 3.7 |
| Current year | 2.86 | | 3.7 |
| 1 year | 0.68 | | 4.5 |
| 3 years | 0.51 | | 4.5 |
| 5 years | 0.51 | | 11.96 |
| 10 years | 0.51 | | 86.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Tassé
CEO | Chief Executive Officer | 66 | 28/11/2018 |
| Director of Finance/CFO | 56 | 05/11/2023 | |
| Chief Operating Officer | - | 30/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Goller
BRD | Director/Board Member | 51 | 20/10/2015 |
Maïlys Ferrère
BRD | Director/Board Member | 62 | 20/06/2016 |
Julie O'Neill
BRD | Director/Board Member | 59 | 14/06/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +18.90% | +21.65% | +308.89% | +25.85% | 1.26B | |
| +0.85% | +1.33% | -8.03% | -32.50% | 65.56B | |
| +0.41% | +0.72% | +12.34% | -9.80% | 8.5B | |
| -0.85% | -1.74% | +29.95% | +35.20% | 8.37B | |
| +0.67% | -3.76% | +9.75% | +66.30% | 6.4B | |
| -0.28% | -4.77% | -19.48% | +113.76% | 5.47B | |
| -1.05% | -8.18% | +179.31% | +32.82% | 4.06B | |
| -0.70% | -2.10% | -10.96% | -17.61% | 3.01B | |
| -0.52% | -2.17% | +32.49% | +24.25% | 2.87B | |
| +1.89% | +3.79% | +56.78% | +44.94% | 2.77B | |
| Average | +1.93% | +0.91% | +59.10% | +28.32% | 10.83B | |
| Weighted average by Cap. | +0.70% | +0.33% | +10.35% | -5.23% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.34M 6.19M 4.97M 4.63M 8.61M 562M 9.27M 57.16M 22.54M 268M 23.22M 22.74M 978M | 4.05M 4.7M 3.77M 3.51M 6.54M 427M 7.04M 43.41M 17.12M 204M 17.64M 17.27M 743M |
| Net income | -117M -135M -109M -101M -188M -12.27B -202M -1.25B -492M -5.86B -507M -497M -21.38B | -120M -139M -111M -104M -193M -12.58B -208M -1.28B -505M -6B -520M -509M -21.92B |
| Net Debt | -70.79M -82.11M -65.9M -61.35M -114M -7.45B -123M -758M -299M -3.55B -308M -302M -12.98B | -70.94M -82.29M -66.04M -61.48M -114M -7.47B -123M -760M -300M -3.56B -309M -302M -13B |
More financial data
* Estimated data
Employees
117
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 3.680 € | +18.90% | 4,170,594 |
| 15/01/26 | 3.095 € | +1.48% | 1,117,837 |
| 14/01/26 | 3.050 € | +2.52% | 800,111 |
| 13/01/26 | 2.975 € | -4.03% | 867,876 |
| 12/01/26 | 3.100 € | +2.48% | 937,208 |
Real-time Euronext Paris, January 16, 2026 at 04:55 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.680EUR
Average target price
4.190EUR
Spread / Average Target
+13.86%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DBV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition